Login to your account

Username *
Password *
Remember Me
Bibliographie

Bibliographie (2322)

Understanding post-COVID-19 interstitial lung disease: a new fibroinflammatory disease entity.

jeudi, 29 septembre 2022 13:39 Écrit par

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity – Intensive Care Medicine   Commentary on Twitter Post #COVID19 interstitial lung disease?? PC-ILD fibroinflammatory disease ? etiopathogenesisIdentifying risk factors & understanding immunopathomechanisms critical to facilitate early intervention to prevent, slow or arrest lung damage progression.?https://t.co/OEM2W9bAEd pic.twitter.com/m4w4qUXl9r — Intensive Care Medicine (@yourICM) September 8, […]

The post Understanding post-COVID-19 interstitial lung disease: a new fibroinflammatory disease entity. appeared first on Links Medicus.

RCT | High-flow nasal cannula oxygen did not reduce mortality in patients with respiratory failure due to COVID-19.

jeudi, 29 septembre 2022 13:39 Écrit par

Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial – JAMA (link to abstract – $ for full-text) Commentary: High-Flow Oxygen Fails to Reduce Mortality due to COVID-19 Respiratory Failure – HCP Live  

The post RCT | High-flow nasal cannula oxygen did not reduce mortality in patients with respiratory failure due to COVID-19. appeared first on Links Medicus.

M-A | Combination therapy with long-acting bronchodilators and risk of adverse cardiovascular events in patients with COPD.

jeudi, 29 septembre 2022 13:39 Écrit par

Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis – European Respiratory Journal (link to abstract – $ for full-text)  

The post M-A | Combination therapy with long-acting bronchodilators and risk of adverse cardiovascular events in patients with COPD. appeared first on Links Medicus.

M-A | Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism.

jeudi, 29 septembre 2022 13:39 Écrit par

Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis – Thrombosis Research   Commentary on Twitter #review Despite its ominous radiologic appearance, clinical behavior and mortality from #saddle pulmonary embolism are comparable to other pulmonary embolism types. https://t.co/NpLs77f5MT pic.twitter.com/2uZ4jhY32G — Thrombosis Research (@ThrombosisRese1) September 5, 2022  

The post M-A | Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism. appeared first on Links Medicus.

M-A of randomized trials | High-flow nasal cannula oxygen therapy vs. non-invasive ventilation for patients with acute exacerbation of COPD after extubation.

mercredi, 21 septembre 2022 22:44 Écrit par

High-Flow Nasal Cannula Oxygen Therapy versus Non-Invasive Ventilation for AECOPD Patients After Extubation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – International Journal of Chronic Obstructive Pulmonary Disease  

The post M-A of randomized trials | High-flow nasal cannula oxygen therapy vs. non-invasive ventilation for patients with acute exacerbation of COPD after extubation. appeared first on Links Medicus.

The Lancet Commission | Towards the elimination of chronic obstructive pulmonary disease.

mercredi, 21 septembre 2022 22:44 Écrit par

Homepage: Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission – The Lancet Commission: Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission Editorial: COPD: from an end-stage disease to lifelong lung health Invited Commentary: Classification of COPD: fostering prevention and precision medicine in the Lancet Commission on COPD Commentary: Proposed classification of COPD according […]

The post The Lancet Commission | Towards the elimination of chronic obstructive pulmonary disease. appeared first on Links Medicus.

M-A of randomized trials | In patients hospitalized with community-acquired pneumonia, corticosteroids reduce the need for mechanical ventilation without significant effects on mortality, treatment failure, or adverse events.

mercredi, 21 septembre 2022 22:44 Écrit par

Effect of corticosteroids on mortality and clinical cure in community-acquired pneumonia: A systematic review, meta-analysis, and meta-regression of randomized control trials – CHEST Journal (link to abstract – $ for full-text) Related: Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm? – European Respiratory Review  

The post M-A of randomized trials | In patients hospitalized with community-acquired pneumonia, corticosteroids reduce the need for mechanical ventilation without significant effects on mortality, treatment failure, or adverse events. appeared first on Links Medicus.

RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events.

mercredi, 21 septembre 2022 22:44 Écrit par

Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial – The Lancet Oncology (free for a limited period)   Commentary on Twitter Our phase III randomized study, published in Lancet Oncology today, showed high-dose steroid didn’t improve SOB and should not be used routinely in pts with lung […]

The post RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events. appeared first on Links Medicus.

RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination.

mercredi, 21 septembre 2022 22:44 Écrit par

Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial – European Heart Journal   Commentary on Twitter In the VIP-ACS trial, among patients hospitalised with an ACS, double dose influenza vaccination before discharge does not reduce cardiovascular and pulmonary outcomes compared with standard dose vaccination ?https://t.co/L9e7MXWfWV#EHJ #ESCCongress @ehj_ed @rladeiraslopes pic.twitter.com/95o50krrwm — European Society of […]

The post RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination. appeared first on Links Medicus.

RCT | Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19.

mercredi, 21 septembre 2022 22:44 Écrit par

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial – The Lancet Respiratory Medicine   Commentaries on Twitter Interesting results in the #PANAMO trial of vilobelimab, an anti-C5a antibody, in critically ill ICU patients w/ COVID19. People on MV (n=386) randomized to […]

The post RCT | Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19. appeared first on Links Medicus.